首页> 外国专利> Agents for treating osteoporosis and inhibiting osteoclast formation

Agents for treating osteoporosis and inhibiting osteoclast formation

机译：用于治疗骨质疏松症和抑制破骨细胞形成的药物

页面导航

摘要
著录项
相似文献

摘要

A composition that effectively prevents the manifestation of osteoporosis, the formation of osteoclasts and suppresses a decrease of spongy bone density. The composition primarily contains Cordyceps sinensis or its processed product.

机译：有效防止骨质疏松症的表现，破骨细胞形成并抑制海绵状骨密度降低的组合物。该组合物主要包含 Cordyceps sinensis 或其加工产品。 展开▼

著录项

公开/公告号US7387781B2

专利类型

公开/公告日2008-06-17

原文格式PDF

申请/专利权人 SHIGETOSHI KADOTA;YOSHINOBU HASHIMOTO;CHIA-CHIN SHEU;
展开▼

申请/专利号US20040825585

发明设计人 SHIGETOSHI KADOTA;YOSHINOBU HASHIMOTO;CHIA-CHIN SHEU;
展开▼

申请日2004-04-16

分类号A61K36/068;A61P19/10;

国家 US

入库时间 2022-08-21 20:11:09

相似文献

专利

外文文献

中文文献

1. 木豆素在抑制破骨细胞形成和预防骨质疏松症药物中的应用 [P] . 中国专利： CN107625759A . 2018-01-26

2. 骨质疏松症治疗剂及破骨细胞形成抑制剂 [P] . 中国专利： CN1541704A . 2004-11-03

3. Agents for treating osteoporosis and inhibiting osteoclast formation [P] . 美国专利： US7311919B2 . 2007-12-25

机译：用于治疗骨质疏松症和抑制破骨细胞形成的药物

4. Agents For Treating Osteoporosis And Inhibiting Osteoclast Formation [P] . 美国专利： US2007014811A1 . 2007-01-18

机译：用于治疗骨质疏松症和抑制破骨细胞形成的药物

5. Agents for treating osteoporosis and inhibiting osteoclast formation [P] . 美国专利： US2005013830A1 . 2005-01-20

机译：用于治疗骨质疏松症和抑制破骨细胞形成的药物

1. New simulation model for bone formation markers in osteoporosis patients treated with once-weekly teriparatide [J] . Sakae Tanaka, Taiji Adachi, Tatsuhiko Kuroda, 骨研究（英文版） . 2014,第004期

2. New simulation model for bone formation markers in osteoporosis patients treated with once-weekly teriparatide [J] . Sakae Tanaka, Taiji Adachi, Tatsuhiko Kuroda, 骨研究：英文 . 2014,第004期

3. Lrp1 in osteoblasts controls osteoclast activity and protects against osteoporosis by limiting PDGF–RANKL signaling [J] . Alexander Bartelt, Martin Dietrich, Jan P.Tuckermann, 骨研究（英文版） . 2018,第001期

4. Lrp1 in osteoblasts controls osteoclast activity and protects against osteoporosis by limiting PDGF–RANKL signaling [J] . Alexander Bartelt, Friederike Behler-Janbeck, F.Timo Beil, 骨研究：英文 . 2018,第001期

5. Curcumin Inhibits ROS Formation and Apoptosis in Methylglyoxal-Treated Human Hepatoma G2 Cells [C] . WEN-HSIUNG CHAN, HSIN-JUNG WU, YAN-DER HSUUW Asian Society for Mitochondrial Research and Medicine . 2005

6. Part I. Development of new organic synthetic methods: Palladium and copper catalyzed carbon-carbon, carbon-sulfur, carbon-nitrogen, and carbon-oxygen bond formation as well as DABCO-mediated stereospecific synthesis of acrylate ethers and amines. Part II. Design, synthesis and SAR studies of new classes of agents to treat drug-resistant bacteria, anthrax and tuberculosis infections. [D] . Kabir, Mohd Shahjahan. 2011

7. Reveromycin A an agent for osteoporosis inhibits bone resorption by inducing apoptosis specifically in osteoclasts [O] . Je-Tae Woo, Makoto Kawatani, Masanori Kato, 2006

8. Reveromycin A, an agent for osteoporosis, inhibits bone resorption by inducing apoptosis specifically in osteoclasts [O] . Woo, Je-Tae, Kawatani, Makoto, Kato, Masanori, 2006

9. Evaluation of Chemical Agents for Inhibiting Acid Mine Drainage Formation [R] . Nebgen, J. W. , Weatherman, D. F. 1979

1. Study and analysis on the mechanisms of action of cytokines on osteoclasts in osteoporosis [J] . Jin-Mei Zhang ,Yan Yin ,Xin-Qi Liu . TMR理论与假说 . 2020,第004期

2. 铝能够抑制破骨细胞形成和减弱破骨细胞骨吸收活性 [C] . 李丙云 ,裴俊瑞 ,高彦辉 . 第七次全国地方病学术会议 . 2011

3. 桃叶珊瑚苷通过抑制与Nrf2介导的抗氧化相关的破骨细胞分化来改善骨质疏松症的研究 [A] . 宋民凯 . 2021